Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-06

Clinical Trial Update: Anakinra vs. Steroids for the Treatment of Gout Attacks in Patients With Renal Disease (ASGARD): A Feasibility Study [Phase 2, Phase 3]

View source ↗

Summary

A feasibility study comparing anakinra versus steroids for treating gout attacks in patients with renal disease (ASGARD) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anakinra (anakinra)
  • steroids

Snippet

Sponsor: Mid and South Essex NHS Foundation Trust | Conditions: Gout, Chronic Kidney Diseases | Phase 2, Phase 3 | Status: COMPLETED